Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matyas

Showing results (1091-1100 of 1,118) with videos related to

Pageof 112
Sort By:
Vaccines|October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient TransfectionAgnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 31, 2018
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialMukul Sharma, Robert G Hart, Eric E Smith, et al.
Lancet (London, England)|June 14, 2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Journal of Thrombosis and Haemostasis : JTH|May 25, 2023
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trialPrapa Kanagaratnam, Darrel P Francis, Daniel Chamie, et al.
European Journal of Pediatrics|May 14, 2025
Pain management in preterm infants with necrotizing enterocolitis: an international expert consensus statementJudith A Ten Barge, Gerbrich E van den Bosch, Karel Allegaert, et al.
Lancet (London, England)|June 14, 2019
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trialHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Journal of Medical Genetics|December 15, 2011
Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndromeIngrid M B H van de Laar, Denise van der Linde, Edwin H G Oei, et al.
Science Advances|November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFNJingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant LineageXianding Deng, Wei Gu, Scot Federman, et al.
Pageof 112

Showing results (1091-1100 of 1,118) with videos related to

Sort By:
Pageof 112
Vaccines|October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient TransfectionAgnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 31, 2018
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialMukul Sharma, Robert G Hart, Eric E Smith, et al.
Lancet (London, England)|June 14, 2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Journal of Thrombosis and Haemostasis : JTH|May 25, 2023
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trialPrapa Kanagaratnam, Darrel P Francis, Daniel Chamie, et al.
European Journal of Pediatrics|May 14, 2025
Pain management in preterm infants with necrotizing enterocolitis: an international expert consensus statementJudith A Ten Barge, Gerbrich E van den Bosch, Karel Allegaert, et al.
Lancet (London, England)|June 14, 2019
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trialHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Journal of Medical Genetics|December 15, 2011
Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndromeIngrid M B H van de Laar, Denise van der Linde, Edwin H G Oei, et al.
Science Advances|November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFNJingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant LineageXianding Deng, Wei Gu, Scot Federman, et al.
Pageof 112